Understanding Visual Confusion Using Stereoscopic Displays

Last updated: June 16, 2023
Sponsor: Massachusetts Eye and Ear Infirmary
Overall Status: Completed

Phase

N/A

Condition

Eye Disorders/infections

Vision Loss

Blurred Vision

Treatment

Bilateral monocular visual confusion (bilateral see-through)

Unilateral monocular visual confusion (unilateral see-through)

Binocular visual confusion (unilateral opaque)

Clinical Study ID

NCT04957745
2021P001757
R01EY031777
  • Ages > 14
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

In this research study we want to test how people understand a visual scene when the same image is presented to both the eyes, but portions of these images are altered in terms of contrast, depth or in some cases motion.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Better than 20/40 visual acuity in the worse eye
  • No restrictions of the peripheral visual field: (at least 60 degrees vertically and 40degrees horizontally)
  • At least 14 years of age (no upper age limit)
  • Able to give voluntary, informed consent
  • Able to understand English
  • Binocular vision parameters within normal limits (Stereopsis ≤ 100 arc sec on anystereo test)

Exclusion

Exclusion criteria:

  • Patients with any physical or mental disabilities, including cognitive dysfunction,balance problems, or other deficits that could impair their ability to respond to thestimuli presented in this study will be excluded
  • Being unable to complete sessions lasting 2-3 hours

Study Design

Total Participants: 13
Treatment Group(s): 3
Primary Treatment: Bilateral monocular visual confusion (bilateral see-through)
Phase:
Study Start date:
November 09, 2021
Estimated Completion Date:
July 27, 2022

Connect with a study center

  • Schepens Eye Research Institute

    Boston, Massachusetts 02114
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.